LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections

[ad_1] SCHLIEREN, Switzerland, October 09, 2023–(BUSINESS WIRE)–LimmaTech Biologics AG today announced the closing of a USD 37 million (CHF 33 million) Series A financing round co-led by Adjuvant Capital, AXA…

Defence to Present Three of Its Leading Products at the Upcoming Festival of Biologics in Basel, Switzerland

[ad_1] Vancouver, British Columbia–(Newsfile Corp. – October 6, 2023) – Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (“Defence” or the “Company“), a Canadian biopharmaceutical company specialized in…

Biologics and Biosimilars Market Size in 2023 | long-term Calculated Business Plan and DRIVING FORCES till 2030

[ad_1] PRESS RELEASE Published September 22, 2023

Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update

[ad_1] Turnstone Biologics Corp. Successfully closed upsized IPO, raising $88 million in gross proceeds to continue advancing pipeline of Selected TIL Therapy programs Cash position expected to fund operations into…

Pharmadule Morimatsu and WuXi Biologics Reached Global Strategic Partnership

[ad_1] SHANGHAI, June 27, 2023 /PRNewswire/ — June 26th, 2023, Pharmadule Morimatsu and WuXi Biologics officially entered into a global strategic cooperation for the Singapore CRDMO Center project of WuXi Biologics.…

World Leading Companies involved in The Cell Line Development for Biologics Market| Business Outlook, Critical Insight,Opportunities, Regional Overview,Business Strategies and Industry Size Forecast to 2030

[ad_1] Business Overview Financial Data Financial – Funding Recent Development and Company Strategy AnalysisContact Us: Stratagem Market Insights UK: +44-203-289-4040 Email: [email protected] 

Biologics Fill Finish Services Markets, 2035 – ResearchAndMarkets.com

[ad_1] Biologics Fill Finish Services Markets, 2035 – ResearchAndMarkets …  WV News [ad_2] Source link